08/22/2022
Tackling Health Equity in Organ Transplantation
07/20/2022
Merge Ahead: The New OPO Landscape & Ways Your OPO Can Prepare
03/29/2022
AlloSeq HCT – The Latest Innovation in NGS-based Chimerism Testing
03/02/2022
Score 6 Advanced Options and Troubleshooting Tips – Fast Results with Automated Analysis
01/26/2022
Transplant Quality Outcomes – Part 2: Leveraging New & Existing Tools to Manage Your Quality Outcomes:…
01/19/2022
Managing Your Outcomes in a World of Imperfect Organs and Higher Risk Recipients
01/19/2022
Optimizing For The Long-Term Success Of Transplant Patients
12/09/2021
Making Waitlist Management More Efficient Part 2
12/01/2021
Improving your CareDx Surveillance Testing Workflows
11/30/2021
Making Waitlist Management More Efficient – Part 1
11/16/2021
Surviving and Thriving in the New Organ Allocation Systems – Part 2
11/11/2021
Improving your CareDx Surveillance Testing Workflows
11/09/2021
Surviving and Thriving in the New Organ Allocation Systems – Part 1
09/24/2021
Role of Inflammation and Injury Post Heart Transplantation
08/29/2021
ESOT 2021 – Symposium – Changing the Transplant Care Paradigm Advanced Strategies for Allograft…
08/10/2021
AlloSeq cfDNA Webinar 2021, English + Portuguese–Organ Transplant Surveillance with AlloSeq cfDNA
06/30/2021
2021 ESOT Webinar
06/30/2021
ADN libre de células derivado de donante (dd-cfDNA): Vigilancia personalizada no invasiva en postrasplante
06/07/2021
CareDx 6/7 ATC Symposium: Advancing Care in Kidney Transplantation – Groundbreaking Findings from ADMIRAL…
06/06/2021
CareDx 6/6 ATC Symposium: AlloSure- dd-cfDNA Utility Beyond Kidney Transplantation
05/12/2021
COVID-19 Vaccines and the Latest Data on Immune Response in Transplant Patients
05/11/2021
HeartCare: The Utility of Multi-Modality in Transplant Patient Care
05/11/2021
AlloSure Lung: Donor-Derived Cell Free DNA as an Innovative Biomarker for Lung Transplant Patients
04/28/2021
Decreasing Transplant Wait Times by Increasing Living Donation